HIV/AIDS Topics AIDS 2016: Gains in Curbing HIV Could Be Lost Without Continued Commitment
- Details
- Category: HIV Treatment
- Published on Monday, 18 July 2016 00:00
- Written by Liz Highleyman
Participants at the 21st International AIDS Conference (AIDS 2016), taking place this week in Durban, South Africa, reviewed the remarkable gains that have been made in access to HIV treatment and new prevention tools since the conference was last held here 16 years ago. But researchers, activists, and government leaders agreed that this progress could be reversed if stakeholders do not commit to increased funding and respect for the human rights of key populations at risk.
AIDS 2016: International AIDS Conference Starts Next Week in Durban
- Details
- Category: HIV Treatment
- Published on Tuesday, 12 July 2016 00:00
- Written by Liz Highleyman
The 21st International AIDS Conference (AIDS 2016) opens next Monday, July 18, in Durban, South Africa, 16 years after the groundbreaking conference in the same city that put the spotlight on global access to new life-saving treatment for people living with HIV and AIDS. This year's theme -- Access, Equity, Rights Now -- recognizes the barriers that still need to be overcometo achieve universal access. HIVandHepatitis.comand collaborator Aidsmap.comwill provide on-site coverage starting on July 17. Follow @HIVandHepatitison Twitter and visit our AIDS 2016 conference page (coming soon) or Facebook pagefor the latest news.
AIDS 2016: International AIDS Conference Coming Up in Durban
- Details
- Category: HIV Treatment
- Published on Tuesday, 05 July 2016 00:00
- Written by Liz Highleyman
The 21st International AIDS Conference (AIDS 2016) will take place July 18-22 in Durban, South Africa, 16 years after the groundbreaking conference in the same city that put the spotlight on global access to new life-saving treatment for people living with HIV and AIDS. This year's theme -- Access, Equity, Rights Now -- recognizes the barriers that still need to be overcometo achieve universal access. HIVandHepatitis.com and collaborator Aidsmap.com will provide comprehensive on-site coverage starting July 18. Follow @HIVandHepatitison Twitter and see our AIDS 2016 conference page (coming soon) or Facebook page for the latest news.
ASM Microbe 2016: Switching from Tenofovir DF to TAF Improves Bone and Kidney Safety
- Details
- Category: HIV Treatment
- Published on Sunday, 10 July 2016 00:00
- Written by Liz Highleyman
People with HIV who switched from the older tenofovir disoproxil fumarate (TDF) formulation to tenofovir alafenamide (TAF) were more likely to maintain viral load suppression and showed improvements in bone density and kidney function biomarkers, according studies presented at the 2016 ASM Microbe conference last month in Boston.
ASM Microbe 2016: New Integrase Inhibitor Bictegravir Looks Promising in Early Studies
- Details
- Category: HIV Treatment
- Published on Monday, 04 July 2016 00:00
- Written by Liz Highleyman
Gilead Sciences' novel integrase inhibitor bictegravir (formerly GS-9883) demonstrated favorable pharmacokinetics, good tolerability, an improved resistance profile compared to older drugs in its class, and potent antiviral activity in laboratory and human studies, according to a set of posters presented at ASM Microbe 2016 last month in Boston.
ART Reduces Opportunistic Illnesses in Children and Adults with HIV
- Details
- Category: HIV Treatment
- Published on Wednesday, 06 July 2016 00:00
- Written by Liz Highleyman
A pair of comprehensive reviews supported by the World Health Organization (WHO) have found that prompt initiation of antiretroviral therapy (ART) is associated with a lower risk of developing opportunistic infections and other HIV-related illnesses in children and adults living with HIV. Both reviews were published in the June 15 edition of Clinical Infectious Diseases.
Coverage of ASM Microbe 2016 (ICAAC 2016)
- Details
- Category: HIV Treatment
- Published on Friday, 01 July 2016 00:00
- Written by HIVandHepatitis.com
HIVandHepatitis.com coverage of ASM Microbe 2016 -- a new conference incorporating the American Society for Microbiology annual meeting and the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) -- Boston, June 16-20, 2016.
Highlights of this year's conference include antiretroviral drugs and treatment strategies, HIV pre-exposure prophylaxis (PrEP), microbiome research, antibiotic resistance, and emerging viruses including Zika.
Full coverage listing by topic
7/1/16
More Articles...
- ASM Microbe 2016: Atripla 3 Times Weekly Maintains HIV Viral Suppression
- New California Grants Address Disparities in HIV Prevention and Care
- Less Frequent CD4 and Viral Load Monitoring Safe for People Doing Well on ART
- ASM Microbe 2016: PRO 140 Antibody Injections Maintain Viral Suppression Off ART
- Big Increase in Proportion of HIV+ People with Viral Suppression in US
Web Design and Development by